The Science Underlying the Probiotic Strain Bifidobacterium in Beneficial Effects on Immunological and Gastrointestinal Health
-
Published:2024-02-21
Issue:1
Volume:12
Page:10-18
-
ISSN:2329-1753
-
Container-title:International Journal of Immunology
-
language:en
-
Short-container-title:IJI
Author:
Ali Ayub1, Islam Nazrul2, Fakir Nazrul Islam3, Kabir Ahsan4, Sharmin Mowmita4, Islam Tazul5, Rahman Masudur6, Badal Fakrul Amin7, Taher Abu8
Affiliation:
1. Department of Pediatrics, President Abdul Hamid Medical College Hospital, Kishoreganj, Bangladesh 2. Department of Neonatology, Mymensingh Medical College & Hospital, Mymensingh, Bangladesh 3. Department of Pediatrics, Shah Sultan Diagnostic Center & Hospital, Sherpur, Bangladesh 4. Department of Pediatrics, Adhunik Sadar Hospital, Netrakona, Bangladesh 5. Department of Pediatrics, Jamalpur General Hospital, Jamalpur, Bangladesh 6. Department of Pediatrics, Shahjamal General Pvt. Hospital, Jamalpur, Bangladesh 7. Department of Pediatrics, Ziaur Rahman Medical College & Hospital, Tangail, Bangladesh 8. Department of Pediatrics, Sheikh Hasina Medical College & Hospital, Tangail, Bangladesh
Abstract
Probiotics have demonstrated a lot of promise in improving gut health in humans. Despite the encouraging data, nothing is known about the therapeutic effectiveness of many of the probiotics on the market, and it's sometimes unclear how they work. Humans have long used Bifidobacterium, a well-known, multifunctional probiotic, to treat gastrointestinal, immunological, and infectious disorders. It is also therapeutically useful. This review provides a theoretical framework for comprehending the mechanisms of action of Bifidobacterium and highlights the functional advantages from the most pertinent animal and clinical trials. The genus Bifidobacterium belongs to the Actinobacteria phylum. = Firmicutes, Bacteroidetes, and Actinobacteria constitute the most abundant phyla in the human intestinal microbiota, Firmicutes and Bacteroidetes being predominant in adults, and Actinobacteria in breast-fed infants, where bifidobacteria can reach levels higher than 90% of the total bacterial population. They are among the first microbial colonizers of the intestines of newborns, and play key roles in the development of their physiology, including maturation of the immune system and use of dietary components. Indeed, some nutrients, such as human milk oligosaccharides, are important drivers of bifidobacterial development. Some Bifidobacterium strains are considered probiotic microorganisms because of their beneficial effects, and they have been included as bioactive ingredients in functional foods, mainly dairy products, as well as in food supplements and pharma products, alone, or together with, other microbes or microbial substrates. Well-documented scientific evidence of their activities is currently available for bifidobacteria containing preparations in some intestinal and extraintestinal pathologies. In particular, it regulates luminal metabolism, maintains gut microbiota stability, and eventually promotes a precisely calibrated homeostatic equilibrium in the host-microbiome relationship. An ideal probiotic selection would benefit from clinical proof of the multifunctional activities' efficacy and mechanism of action.
Publisher
Science Publishing Group
Reference77 articles.
1. Zhou, B.; Yuan, Y.; Zhang, S.; Guo, C.; Li, X.; Li, G.; Xiong, W.; Zeng, Z. Intestinal Flora and Disease Mutually Shape the Regional Immune System in the Intestinal Tract. Front. Immunol. 2020, 11, 575. 2. Sharifi-Rad, J.; Rodrigues, C. F.; Stojanovi´c-Radi´c, Z.; Dimitrijevi´c, M.; Aleksi´c, A.; Neffe-Skocinska, K.; Zieli ´nska, D.; Kołozyn- ˙ Krajewska, D.; Salehi, B.; Prabu, S. M.; et al. Probiotics: Versatile Bioactive Components in Promoting Human Health. Medicina 2020, 56, 433. 3. Lee, J.-Y.; Tsolis, R. M.; Bäumler, A. J. The microbiome and gut homeostasis. Science 2022, 37, eabp9960. [CrossRef] [PubMed]. 4. Chinda, D.; Takada, T.; Mikami, T.; Shimizu, K.; Oana, K.; Arai, T.; Akitaya, K.; Sakuraba, H.; Katto, M.; Nagara, Y.; et al. Spatial distribution of live gut microbiota and bile acid metabolism in various parts of human large intestine. Sci. Rep. 2022, 12, 1–18. [CrossRef] [PubMed]. 5. Yan, F.; Polk, D. B. Probiotics and immune health. Curr. Opin. Gastroenterol. 2011, 27, 496–501. [CrossRef].
|
|